<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>MDLZ on Deep Analyst AI</title><link>https://deepanalyst.ai/tags/MDLZ/</link><description>Recent content in MDLZ on Deep Analyst AI</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Tue, 03 Feb 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://deepanalyst.ai/tags/MDLZ/rss.xml" rel="self" type="application/rss+xml"/><item><title>The $152 Billion Sugar Rush: Mondelēz is Selling "Health" to Hedonists</title><link>https://deepanalyst.ai/posts/2026/02/mdlz-152-billion-sugar-rush-mondel-z-is-selling-health-hedonists/</link><pubDate>Tue, 03 Feb 2026 00:00:00 +0000</pubDate><guid>https://deepanalyst.ai/posts/2026/02/mdlz-152-billion-sugar-rush-mondel-z-is-selling-health-hedonists/</guid><description>The $152 Billion Sugar Rush: Mondelēz is Selling &amp;ldquo;Health&amp;rdquo; to Hedonists Investing in chocolate isn’t about whimsy or hunting for golden tickets; it’s about capitalizing on a legal, serotonin-inducing addiction that consistently survives every economic downturn. While tech investors hyperventilate over AI hallucinations, the global palate is doubling down on a much stickier asset class.
According to a bombshell analysis for 2026, we are staring down the barrel of a market rocketing toward $145.</description></item></channel></rss>